Akzo Nobel confirms the signed contract to buy Hoechst Roussel Vet after European Commission clearance, at approximately EUR 655 million, making Intervet the fourth-largest animal-health company.
Intervet, the veterinary business unit of Akzo Nobel, moved to the number four position in animal healthcare, after Akzo Nobel signed a contract on Friday to buy Hoechst Roussel Vet, the veterinary business of Hoechst AG. Closing of the deal follows the European Commission's approval of the transaction last week.
Akzo Nobel confirms the signed contract to buy Hoechst Roussel Vet after European Commission clearance, at approximately EUR 655 million, making Intervet the fourth-largest animal-health company. Neutral corporate disclosure. Consideration in this release 'approximately EUR 655 million' (the August release said EUR 665 million) – both figures recorded as published. Intervet headquartered in Boxmeer, Netherlands. EC clearance is the M.1378 decision of 1999-08-09 (FBB-18). Context: this moved the fenbendazole business to Intervet in late 1999. Study type: news.
